BRIEF CURRICULUM VITAE
ATHANASIOS E RAPTIS, MD, PhD.
ASSOCIATE PROFESSOR OF INTERNAL MEDICINE-DIABETES MELLITUS
FACULTY OF MEDICINE
NATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS
Personal Information
Address: 2nd Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes
Center, Attikon University Hospital, 1 Rimini str., 12462 Athens, Greece
tel.: +30-210 5832357
fax: +30-210 58319127
e-mail:atraptis@med.uoa.gr
e-mail: atraptis@otenet.gr
Education
Athens University Medical School.
Postgraduate
-Doctoral Thesis in Athens University Medical School
Titles
'Clinical and Biochemical Parameters after prolonged
administration of semisynthetic
human insulin in newly
diagnosed insullin-dependent diabetics. Comparative study with
purified insulin".
-I was granted
with
a scholarship by " Alexandros Onassis"
foundation ( Oct.1983 - Sept.1984 )
-I was granted
with
a scholarship by " Hellenic Diabetic
Association" ( April 1995 - April 1997 )
Speciality
Internal Medicine
Subspeciality
Diabetes Mellitus
Previous Employment
1981 Nov.- 1982 Sept.:
Research Fellow in Diabetes Center - Artificial Pancreas Unit
of the Department of Clinical Therapeutics in"Alexandra
Hospital", Athens University.
1982 Nov.- 1985 Mar.:
Research Fellow in the 2nd Department of Internal Medicine Propaedeutic,of Athens University in "Evangelismos Hospital"
( Chairman:Professor S.A.Raptis M.D.).
1985 Apr.- 1987 Jan.:
Served as a Doctor in the Armed Forces (July 1985 - March
1986, Resident in the Department of Internal Medicine of 218
Military Hospital,
April 1986 - January 1987,Resident in the Department of
Internal Medicine of 401 Military Hospital).
1987 Mar.-1988 Febr.:
State Doctor in rural area for one year (Obligatory).
1988 Mar.- 1989 Mar.:
Research Fellow in the 2nd Department of Internal Medicine
Propaedeutic of Athens University, "Evangelismos Hospital"
1989 Apr.- 1992 Oct.:
Resident in the 2nd Department of Internal Medicine,
Propaedeutic of Athens University,"Evangelismos Hospital"
1992 Nov.- 1994 Mar.:
Research Fellow in the 2nd Department of Internal Medicine
Propaedeutic of Athens University, "Evangelismos Hospital"
1994 Mar.- 1995 Apr.:
Registrar in the 2nd Department of Internal Medicine
Propaedeutic of Athens University,"Evangelismos Hospital"
1995 Apr. - 1997 Apr.:
Honorary Research Fellow in the Unit for Metabolic Medicine
of London University, Guy's Hospital, U.K. (Chairman:
Professor GianCarlo Viberti)
1997 Apr. – 2002 Jul :
Registrar in the 2nd Department of Internal Medicine
Propaedeutic of Athens University,"Evangelismos Hospital"
2002 Jul. – 2003 Nov :
Lecturer in the 2nd Department of Internal Medicine
Propaedeutic of Athens University,"Evangelismos Hospital"
2
2003 Nov. –2007 Aug :
Lecturer in the 2nd Department of Internal Medicine
Propaedeutic of Athens University,"Attikon Hospital"
2007 Aug. –2012 Sept : Assistant Professor in the 2nd Department of Internal Medicine
Propaedeutic of Athens University,"Attikon Hospital"
2012 Sept. - Today :
Associate Professor in the 2nd Department of Internal Medicine
Propaedeutic of Athens University,"Attikon Hospital"
Special Fields
- Diabetes Mellitus
of Study
- Hypertension
- Diabetic Nephropathy
Membership of
- European Association for the Study of Diabetes (EASD)
Scientific
- Hellenic Diabetological Association
Society
- Hellenic Association of Internal Medicine
- Hellenic Transplantation Society
- General Medical Council (GMC)
I have received the Good Clinical Practice (GCP) training
3
PAPERS
1.
a)Raptis S., Hadjidakis D, Enzmann F, Raptis A, Diamantopoulos E, Rosenthal J
Inhibition of pancreatic glucagon-responses to arginine by human insulin (recombinant
DNA) and purified porcine insulin in normal and diabetic subjects
DIABETES CARE 5: 93-101 Suppl. 2, 1982
b)Raptis S., Hadjidakis D, Enzmann F, Raptis A, Diamantopoulos E, Rosenthal J
Inhibition of pancreatic glucagon-responses to arginine by human insulin (recombinant
DNA) and purified porcine insulin in normal and diabetic subjects
MUNCHENER MEDIZINISCHE WOCHENSCHRIFT,125,38-43, Suppl. 1, 1983
2.
Dimitriadis G, Raptis S, Raptis A, Hatziagelaki E, Mitrakou A, Halvatsiotis P, Ladas S,
Hillebrand I
Effects of 2 new alpha-glucosidase inhibitors on glycemic control in patients with insulindependent diabetes-mellitus
KLINISCHE WOCHENSCHRIFT 64 (9): 405-410 May 2 1986
3. Hadjidakis DI, Raptis SA, Raptis AE, Karaiskos C, Souvatzoglou A, Diamantopoulos EJ
The antidiabetic action of somatostatin-28 as assessed by the artificial endocrine
pancreas - greater potency than somatostatin-14
HORMONE AND METABOLIC RESEARCH 19 (11): 574-578 NOV 1987
4. Raptis AE, Tountas N, Yalouris AG, Hadjidakis D, Zaharis A, Miras K, Raptis SA
Comparative-study of the therapeutic effects of glibenclamide or the fixed combination of
glibenclamide - phenformin with those of gliclazide or chlorpropamide
ACTA DIABETOLOGICA LATINA 27 (1): 11-22 Jan-Mar 1990
5. Raptis AE, Tountas NB, Yalouris AG, Halvatsiotis PG, Raptis SA
Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in
NIDDM patients
HORMONE AND METABOLIC RESEARCH 28 (2): 89-94 FEB 1996
6. Raptis AE, Spring MW, Viberti G
Comparison of blood pressure measurement methods in adult diabetics
LANCET 349 (9046): 175-176 JAN 18 1997
7 . Mitrakou A, Tountas N, Raptis AE, Bauer RJ, Schulz H, Raptis SA
Long-term effectiveness of a new alpha-glucosidase inhibitor (bay m1099-miglitol) in
insulin-treated type 2 diabetes mellitus
DIABETIC MEDICINE 15 (8): 657-660 AUG 1998
8 . Raptis SA, Hatziagelaki E, Dimitriadis G, Draeger KE, Pfeiffer C, Raptis AE
Comparative effects of glimepiride and glibenclamide on blood glucose, c-peptide and
insulin concentrations in the fasting and postprandial state in normal man
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 107 (6): 350-355
1999
9. Raptis AE, Viberti G
Pathogenesis of diabetic nephropathy
4
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES 109: S424-S437
Suppl. 2 2001
10. Hadjidakis DJ, Mylonakis AM, Sfakianakis ME, Raptis AE, Raptis SA
Diabetes and premature menopause: is their co-existence detrimental to the skeleton?
EUROPEAN JOURNAL OF ENDOCRINOLOGY 152 (3): 437-442 MAR 2005
11. Hadjidakis DJ, Raptis AE, Sfakianakis ME, Mylonakis AM, Raptis SA.
Bone mineral density of both genders in type 1 diabetes according to bone composition.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, Sep-Oct;20(5):302-7,2006
12. Kyriakides Z. S, Kremastinos D., Raptis A. E., Kyrzopoulos S., Raptis S. A.,
Sbarouni E., Johnston N., Webb D. J
Impaired effect of endogenous endothelin-1 on coronary artery stiffness in patients with
type II diabetes mellitus.
INTERNATIONAL JOURNAL OF CARDIOLOGY, Sep 20 ; 112(2):207- 12, 2006
13. Hadjidakis DI, Androulakis II, Mylonakis AM, Sfakianakis ME, Raptis AE,
Papaefstathiou AG, Economopoulos TC, Raptis SA.
Diabetes in postmenopause: different influence on bone mass according to age and
disease duration.
EXP CLIN ENDOCRINOL DIABETES. May;117(5):199-204, 2009
14. Mitrou P, Boutati E, Lambadiari V, Tsegka A, Raptis AE, Tountas N, Economopoulos T,
Raptis SA, Dimitriadis G.
Insulin resistance in hyperthyroidism: the role of IL6 and TNF alpha.
EUR J ENDOCRINOL. Jan;162(1):121-6, 2010
15. Mitrou P, Raptis AE, Lambadiari V, Boutati E, Petsiou E, Spanoudi F, Papakonstantinou
E, Maratou E, Economopoulos T, Dimitriadis G, Raptis SA.
Vinegar decreases postprandial hyperglycemia in patients with type 1 diabetes.
DIABETES CARE. Feb;33(2):e27, 2010
16. Dimitriadis G, Boutati E, Raptis AE, Hatziagelaki E, Mitrou P, Lambadiari V, Tountas N,
Economopoulos T, Raptis SA.
Subcutaneous glucose monitoring with GlucoDay: comparison of the results to those
obtained with the endocrine artificial pancreas.
HORMONES (Athens) Apr-Jun;9(2):145-50, 2010
17. Lambadiari V, Mitrou P, Maratou E, Raptis AE, Tountas N, Raptis SA, Dimitriadis G.
Thyroid hormones are positively associated with insulin resistance early in the
development of type 2 diabetes.
ENDOCRINE. Feb;39(1):28-32, 2011
18. Dimitriadis G, Hatziagelaki E, Mitrou P, Lambadiari V, Maratou E, Raptis AE, Gerich JE,
Raptis SA.
5
Effect of Hyperthyroidism on Clearance and Secretion of Glucagon in Man.
Exp Clin Endocrinol Diabetes. Apr 119(4), 214-217, 2011
19. Raptis A., Markakis K., Mazioti M., Raptis S., Dimitriadis G.
What the radiologist needs to know about the diabetic patient
Insights Imaging 2:193-203, 2011
20. Raptis AE, Bacharaki D, Mazioti M, Marathias KP, Markakis KP, Raptis SADimitriadis
GD, Vlahakos DV.
Anemia due to Coadministration of Renin-Angiotensin-System Inhibitors and PPARγ
Agonists in Uncomplicated Diabetic Patients.
Exp Clin Endocrinol Diabetes. Mar 22., 2012
21. Lambadiari V, Mitrou P, Maratou E, Raptis A, Raptis SA, Dimitriadis G.
Increases in muscle blood flow after a mixed meal are impaired at all stages of type 2
diabetes.
Clin Endocrinol (Oxf). Jun;76(6):825-30.,2012
22. Kontoangelos K, Raptis AE, Papageorgiou CC, Tsiotra PC, Papadimitriou GN,
Rabavilas AD, Dimitriadis G, Raptis SA. Oxytocin and psychological factors affecting
type 2 diabetes mellitus.
Exp Diabetes Res. 2012;2012:560864. Epub 2012 Sep 10.
23. Kontoangelos K., Raptis A.E., Papageorgiou C.C., George N.Papadimitriou G.N.,
Rabavilas A.D., Dimitriadis G., 2 and Raptis S.A.
The association opf the metabolic profile in diabetes mellitus type 2 patients with obsessive
compulsive disorder and depression : New insights
International Journal of Psychiatry in Clinical Practice 2013 Feb;17(1):48-55.
Kontoangelos K, Raptis AE, Papageorgiou CC, Tsiotra PC, Papadimitriou GN, Rabavilas
AD, Dimitriadis G, Raptis SA. Oxytocin and psychological factors affecting type 2 diabetes
mellitus.
Exp Diabetes Res.;2012:560864. Epub 2012 Sep 10., 2012
6